As we continue to navigate the challenges brought about by the COVID-19 pandemic, it’s important to shine a light on healthcare elements that may have fallen by the wayside these past two years – like preventive care. For women, these challenges are compounded by a pre-pandemic gap in preventive care accessibility.1 Women’s Health Highlight on […]
Search Results for: log in
25
Jan
Jan
Each January brings the opportunity to discuss a topic of great importance in women’s health – cervical cancer. Learning more about cervical cancer and how testing is performed for early detection can help you know your risk. Here, we offer an overview of the disease and the importance of cervical cancer screening. Cervical Cancer Awareness […]
19
Jan
Jan
According to the American Thyroid Association (ATA), more than 12 percent of the United States population will develop a thyroid condition during their lifetime. Although most thyroid diseases are life-long conditions, the ATA advises that they can be managed with medical attention.1 Thyroid Awareness | Get to Know the Gland This January, observe Thyroid Awareness […]
13
Dec
Dec
This December, BioReference is proud to be celebrating an exciting milestone – our 40th anniversary. For over four decades, our dedicated team has worked to build a legacy of scientific expertise through innovative and tailored laboratory test solutions. Join us in celebrating our 40th anniversary and learn more about our dynamic evolution. BioReference Celebrates 40 […]
08
Dec
Dec
MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved OPKO’s 4Kscore Test. This test is approved for use in men age 45 and older who have not had a prior prostate biopsy or are biopsy negative and have an age-specific abnormal total PSA and/or […]
In case you missed it: Richard Schwabacher, Senior Vice President, Digital Health and Chief Digital Officer, was named a Corporate Finalist for the New York CIO of the Year, for the CIO ORBIE Awards 2021. Skip to the 1:50 mark in the Corporate Finalist video to hear Richard discuss digital transformation and use of technology […]
Press Release
BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.
29
Nov
Nov
ELMWOOD PARK, N.J., November 29, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), announced COVID-19 testing preparedness for the Omicron Variant. BioReference’s PCR diagnostic tests for SARS-CoV-2 COVID-19 are based on recognizing specific RNA target genes that are common to all coronaviruses. To date, the diagnostic targets have not changed with the novel […]
29
Nov
Nov
According to the Centers for Disease Control and Prevention (CDC), outdoor activities are still safer to take part in than indoor activities due to COVID-19.1 Though, with chilly weather settling in in many regions, this may mean changing some of our go-to adventures. Luckily, fall and winter bring a host of new opportunities to enjoy […]
23
Nov
Nov
Thanksgiving brings the beginning of the winter holiday season – a time for connection and celebration. As family gathers around the table to give thanks, a toast to health is often in order. This year, take the opportunity to touch base with your loved ones about important familial health matters like cancer screening for hereditary […]
15
Nov
Nov
As the weather cools and the leaves continue to change, it’s time again to start preparing for cold and flu season. However, with COVID-19 still a pressing issue, and winter allergies emerging, it can often be tough to decipher between illnesses when you feel like you might be coming down with something. Here, we’re breaking […]
